The DermaFloat® LAL is a unique therapy system that provides pressure redistribution by combining low air loss with pulsation. Low air loss therapy has been demonstrated to reduce the risk of pressure ulcers as well as being a valuable aid in the treatment of pressure ulcers. The pulsation feature may provide additional resident comfort and enhance the lymphatic system. The DermaFloat LAL is designed as a mattress replacement system for residents weighing up to 500 lbs.
Clinical indications
- Pressure redistribution: Stage I - IV Pressure Ulcers, Moisture Management Required, Rehabilitation, Burns, Neurology, Dermatology, Amputations
- Pain Management: AIDS, Arthritis, Oncology
